TMCnet News
U.S. Patents Awarded to Inventors in Massachusetts (May 25)(Targeted News Service Via Acquire Media NewsEdge) Targeted News Service Targeted News Service ALEXANDRIA, Va., May 25 -- The following federal patents were awarded to inventors in Massachusetts. *** ASK Diagnostics Assigned Patent ALEXANDRIA, Va., May 25 -- ASK Diagnostics, Norwell, Mass., has been assigned a patent (8,445,220) developed by Geoffrey Schmidt, Norwell, Mass., for "methods of diagnosing latent and active malignancies." The abstract of the patent published by the U.S. Patent and Trademark Office states: "Disclosed are procedures and methods for diagnosing latent and active cancers in a subject. The described methods include the use of sandwich ELISA assays containing antibodies specific for certain epitopes on the A-protein. This enables the assay to discriminate between the monomelic and homopolymeric forms of A-protein." The patent application was filed on Nov. 8, 2012 (13/672,099). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=8,445,220.PN.&OS=PN/8,445,220&RS=PN/8,445,220 Written by Kusum Sangma; edited by Anand Kumar. *** Crucible Intellectual Property Assigned Patent ALEXANDRIA, Va., May 25 -- Crucible Intellectual Property, Rancho Santa Margarita, Calif., has been assigned a patent (8,445,161) developed by Trevor Wende, Boston, for a "current collector plates of bulk-solidifying amorphous alloys." The abstract of the patent published by the U.S. Patent and Trademark Office states: "Collector plates made of bulk-solidifying amorphous alloys, the bulk-solidifying amorphous alloys providing ruggedness, lightweight structure, excellent resistance to chemical and environmental effects, and low-cost manufacturing, and methods of making such collector plates from such bulk-solidifying amorphous alloys are provided." The patent application was filed on Dec. 14, 2010 (12/968,250). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=8,445,161.PN.&OS=PN/8,445,161&RS=PN/8,445,161 Written by Kusum Sangma; edited by Anand Kumar. *** OFS Fitel Assigned Patent ALEXANDRIA, Va., May 25 -- OFS Fitel, Norcross, Ga., has been assigned a patent (8,445,059) developed by five co-inventors for an "accelerated aging of phosphorus-doped optical fibers." The co-inventors are David J. DiGiovanni, Mountain Lakes, N.J., Robert Lingle Jr., Alpharetta, Ga., Michael LuValle, Morristown, N.J., George E. Oulundsen, Belchertown, Mass., and Durgesh Shivram Vaidya, Southbridge, Mass. The abstract of the patent published by the U.S. Patent and Trademark Office states: "Adverse hydrogen aging limitations in multiply-doped optical fibers are overcome by passivating these optical fibers using a deuterium passivation process. This treatment essentially pre-reacts the glass with deuterium so that the most active glass sites are no longer available to react with hydrogen in service. Optical fibers of main interest are doped with mixtures of germanium and phosphorus. Optimum passivating process conditions are described." The patent application was filed on Sept. 5, 2008 (12/231,781). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=8,445,059.PN.&OS=PN/8,445,059&RS=PN/8,445,059 Written by Kusum Sangma; edited by Anand Kumar. *** Xtalic Assigned Patent ALEXANDRIA, Va., May 25 - Xtalic, Marlborough, Mass., has been assigned a patent (8,445,116) developed by five co-inventors for a "coated articles and methods." The co-inventors are Nazila Dadvand, Gatineau, Canada, Christopher A. Schuh, Ashland, Mass., Alan C. Lund, Ashland, Mass., Jonathan C. Trenkle, Cambridge, Mass., and John Cahalen, Somerville, Mass. The abstract of the patent published by the U.S. Patent and Trademark Office states: "Coated articles and methods for applying coatings are described. The article may include a base material and a coating comprising silver formed thereon. In some embodiments, the coating comprises a silver-based alloy, such as a silver-tungsten alloy. The coating may, in some instances, include at least two layers. For example, the coating may include a first layer comprising a silver-based alloy and a second layer comprising a precious metal. The coating can exhibit desirable properties and characteristics such as durability (e.g., wear), hardness, corrosion resistance, and high conductivity, which may be beneficial, for example, in electrical and/or electronic applications. In some cases, the coating may be applied using an electrodeposition process." The patent application was filed on Nov. 27, 2011 (13/304,672). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=8,445,116.PN.&OS=PN/8,445,116&RS=PN/8,445,116 Written by Kusum Sangma; edited by Anand Kumar. *** Brigham and Women's Hospital Assigned Patent ALEXANDRIA, Va., May 25 -- Brigham and Women's Hospital, Boston, has been assigned a patent (8,445,437) developed by Guo-Ping Shi, Newton, Mass., for a "treatment and prevention of cardiovascular disease using mast cell stabilizers." The abstract of the patent published by the U.S. Patent and Trademark Office states: "The present invention is directed to methods of treating or preventing the development of cardiovascular disease by administering compounds that stabilize mast cells. In addition, it includes pharmaceutical compositions which have both a mast cell stabilizer and instructions regarding the use of the stabilizer in treating or preventing cardiovascular disease. The methods and compositions will be of particular value for preventing aneurysms of the abdominal aorta in individuals with atherosclerosis, diabetes, hypertension or a family history of aneurysms." The patent application was filed on July 24, 2007 (11/878,419). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,445,437&OS=8,445,437&RS=8,445,437 Written by Satyaban Rath; edited by Hemanta Panigrahi. *** Brigham and Women's Hospital Assigned Patent ALEXANDRIA, Va., May 25 -- Brigham and Women's Hospital, Boston, has been assigned a patent (8,445,435) developed by Guo-Ping Shi, Newton, Mass., for "mast cell stabilizers in the treatment of obesity." The abstract of the patent published by the U.S. Patent and Trademark Office states: "The present invention is directed to methods of treating or preventing the development of obesity by administering compounds that stabilize mast cells. In addition, it includes pharmaceutical compositions which have both a mast cell stabilizer and instructions regarding the use of the stabilizer in treating or preventing obesity." The patent application was filed on Sept. 24, 2008 (12/232,789). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,445,435&OS=8,445,435&RS=8,445,435 Written by Satyaban Rath; edited by Hemanta Panigrahi. *** Constitution Medical Assigned Patent ALEXANDRIA, Va., May 25 -- Constitution Medical, Boston, has been assigned a patent (8,445,284) developed by Daniel Lapen, Lancaster, Mass., and Kerri Licari, Boston, for "fixative and staining solutions." The abstract of the patent published by the U.S. Patent and Trademark Office states: "The formulations, systems, and methods disclosed herein permit automated preparation of specimens (e.g., biological specimens) for examination. The formulations can include a cytological fixative solution including Azure B, a surfactant, methanol, and ethylene glycol. The disclosed formulations, systems, and methods provide fast, efficient, and highly uniform specimen processing using minimal quantities of fluids. The methods include at least a fixing phase for fixing a specimen to a substrate such as a microscope slide, a staining phase for staining the specimen, and a rinsing phase for rinsing the specimen. One or more of the fixing, staining, and rinsing phases include one or more agitation phases for distributing reagents evenly and uniformly across the specimen. The systems can be implemented as a standalone device or as a component in a larger system for preparing and examining specimens." The patent application was filed on June 18, 2012 (13/526,164). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,445,284&OS=8,445,284&RS=8,445,284 Written by Satyaban Rath; edited by Hemanta Panigrahi. *** Massachusetts Institute of Technology Assigned Patent ALEXANDRIA, Va., May 25 -- Massachusetts Institute of Technology, Cambridge, Mass., has been assigned a patent (8,445,228) developed by Kimberly S. Hamad-Schifferli, Somerville, Mass., and Sunho Park, Silver Spring, Md., for an "enhancement of in vitro translation by nanoparticle conjugates." The abstract of the patent published by the U.S. Patent and Trademark Office states: "Provided herein are kits and methods suitable for enhancing in vitro translation of a nuclei acid sequence of interest." The patent application was filed on Dec. 14, 2009 (12/637,743). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,445,228&OS=8,445,228&RS=8,445,228 Written by Satyaban Rath; edited by Hemanta Panigrahi. *** Invensys Systems Assigned Patent ALEXANDRIA, Va., May 25 -- Invensys Systems, Foxboro, Mass., has been assigned a patent (8,445,289) developed by W. Marcus Trygstad, Spring, Texas, Bruce Keen, Bartlesville, Okla., and Russell Jackson, Sudbury, Mass., for a "system and method for alkylation process analysis." The abstract of the patent published by the U.S. Patent and Trademark Office states: "A method and apparatus is provided for determining concentration of components in a liquid hydrocarbon mixture including hydrocarbons and water flowing through an alkylation process. A fluid flow path conveys the liquid continuously from the alkylation process through a first instrument configured for measuring a property of the liquid mixture, and having responsivities to concentration of the components, which are independent of the concentration of the water. A temperature detector generates temperature data for the liquid, and a second instrument measures another property of the liquid mixture. The instruments have mutually distinct responsivities to concentrations of the components. A processor captures data from the temperature detector and instruments, using the data with a model of responsivities of various concentrations of the components at various temperatures, to determine a temperature compensated concentration of the components while the liquid mixture flows continuously through the fluid flow path." The patent application was filed on March 14, 2012 (13/420,175). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,445,289&OS=8,445,289&RS=8,445,289 Written by Satyaban Rath; edited by Hemanta Panigrahi. *** Dana-Farber Cancer Institute Assigned Patent ALEXANDRIA, Va., May 25 -- Dana-Farber Cancer Institute, Boston, has been assigned a patent (8,445,233) developed by Bruce M. Spiegelman, Waban, Mass., and Jiandie Lin, Ann Arbor, Mich., for a "PGC-1.beta., a novel PGC-1 homologue and uses therefor." The abstract of the patent published by the U.S. Patent and Trademark Office states: "The invention provides isolated nucleic acid molecules, designated PGC-1.beta. nucleic acid molecules, which encode novel PGC-1 related coactivator molecules. The invention also provides antisense nucleic acid molecules, recombinant expression vectors containing PGC-1.beta. nucleic acid molecules, host cells into which the expression vectors have been introduced, and nonhuman transgenic animals in which a PGC-1.beta. gene has been introduced or disrupted. The invention still further provides isolated PGC-1.beta. proteins, fusion proteins, antigenic peptides and anti-PGC-1.beta. antibodies. Diagnostic and therapeutic methods utilizing compositions of the invention are also provided." The patent application was filed on Dec. 21, 2011 (13/333,210). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,445,233&OS=8,445,233&RS=8,445,233 Written by Satyaban Rath; edited by Hemanta Panigrahi. *** Newport Assigned Patent for Performance Optically Coated Semiconductor Devices and Related Methods of Manufacture ALEXANDRIA, Va., May 25 -- Newport, Irvine, Calif., has been assigned a patent (8,445,299) developed by Jamie Knapp, Mendon, Mass., for "performance optically coated semiconductor devices and related methods of manufacture." The abstract of the patent published by the U.S. Patent and Trademark Office states: "The present application disclosed various embodiments of improved performance optically coated semiconductor devices and various methods for the manufacture thereof and includes depositing a first layer of a low density, low index of refraction material on a surface of a semiconductor device, depositing a multi-layer optical coating comprising alternating layers of low density, low index of refraction materials and high density, high index of refraction materials on the coated surface of the semi-conductor device, selectively ablating a portion of the alternating multi-layer optical coating to expose at least a portion of the low density first layer, and selectively ablating a portion of the first layer of low density material to expose at least a portion of the semiconductor device." The patent application was filed on Dec. 11, 2008 (12/741,580). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,445,299&OS=8,445,299&RS=8,445,299 Written by Satyaban Rath; edited by Hemanta Panigrahi. *** Auburn University Assigned Patent ALEXANDRIA, Va., May 25 -- Auburn University, Auburn, Ala., has been assigned a patent (8,445,255) developed by four co-inventors for "inoculants including Bacillus bacteria for inducing production of volatile organic compounds in plants." The co-inventors are Joseph W. Kloepper, Auburn, Ala., Henry Y. Fadamiro, Auburn, Ala., Esther N. Ngumbi, Ukunda, Kenya, and Kate W. Nangle, Waltham, Mass. The abstract of the patent published by the U.S. Patent and Trademark Office states: "Disclosed are inoculants that include Bacillus bacteria and induce production of volatile organic compounds (VOCs) by a plant that has been treated with the inoculant." The patent application was filed on Dec. 12, 2011 (13/323,379). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,445,255&OS=8,445,255&RS=8,445,255 Written by Satyaban Rath; edited by Hemanta Panigrahi. For more information about Targeted News Service products and services, please contact: Myron Struck, editor, Targeted News Service LLC, Springfield, Va., 703/304-1897; [email protected]; http://targetednews.com. -1126216 (c) 2013 Targeted News Service |